CVS Health (CVS) Stock Moves -0.96%: What You Should Know

In the latest trading session, CVS Health (CVS) closed at $44.49, marking a -0.96% move from the previous day. This change was narrower than the S&P 500's daily loss of 1.11%. At the same time, the Dow lost 0.77%, and the tech-heavy Nasdaq lost 1.49%.Heading into today, shares of the drugstore chain and pharmacy benefits manager had lost 25.08% over the past month, lagging the Retail-Wholesale sector's gain of 1.42% and the S&P 500's gain of 0.4% in that time.The investment community will be closely monitoring the performance of CVS Health in its forthcoming earnings report. The company's upcoming EPS is projected at $1.02, signifying a 51.89% drop compared to the same quarter of the previous year. Meanwhile, our latest consensus estimate is calling for revenue of $97.27 billion, up 3.69% from the prior-year quarter.In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $5.29 per share and a revenue of $371.96 billion, indicating changes of -39.47% and +3.96%, respectively, from the former year.Investors might also notice recent changes to analyst estimates for CVS Health. These latest adjustments often mirror the shifting dynamics of short-term business patterns. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 1.49% downward. CVS Health currently has a Zacks Rank of #3 (Hold).Digging into valuation, CVS Health currently has a Forward P/E ratio of 8.49. This expresses a premium compared to the average Forward P/E of 6.39 of its industry.One should further note that CVS currently holds a PEG ratio of 0.78. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. As the market closed yesterday, the Retail - Pharmacies and Drug Stores industry was having an average PEG ratio of 0.78.The Retail - Pharmacies and Drug Stores industry is part of the Retail-Wholesale sector. At present, this industry carries a Zacks Industry Rank of 186, placing it within the bottom 26% of over 250 industries.The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.Zacks Naming Top 10 Stocks for 2025Want to be tipped off early to our 10 top picks for the entirety of 2025?History suggests their performance could be sensational.From 2012 (when our Director of Research Sheraz Mian assumed responsibility for the portfolio) through November, 2024, the Zacks Top 10 Stocks gained +2,112.6%, more than QUADRUPLING the S&P 500’s +475.6%. Now Sheraz is combing through 4,400 companies to handpick the best 10 tickers to buy and hold in 2025. Don’t miss your chance to get in on these stocks when they’re released on January 2.Be First to New Top 10 Stocks >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report CVS Health Corporation (CVS): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks